As early adopters have discovered, Copilot delivers real transformation only when it becomes an integral part of critical ...

Ottawa approves a framework allowing a privately financed oil pipeline to move Alberta crude to Asia, marking a major shift away from Canada’s decarbonization agenda. The project faces strong ...

Mikel Arteta has delivered a clear message to £64 million signing Viktor Gyokeres, insisting that “two things have to merge” for the Swedish striker to thrive at Arsenal. The manager believes both ...

Coherus Oncology maintains a 'Buy' rating, driven by a promising clinical pipeline and undervaluation relative to cash and equity holdings. CHRS's commercial growth is anchored by toripalimab sales in ...

Tango Therapeutics (TNGX) has quietly turned into a strong performer, with the stock up roughly 200% this year and more than tripling over the past year as investors reassess its oncology pipeline.

After taking a shot at becoming a neuroscience biotech, buzzy Bay Area AI outfit Verge Genomics is dropping its only clinical asset and returning to its drug discovery roots. The decision comes after ...

AbCellera, despite massive investments in technology and talent, remains an expensive biotech with little short-term revenue avenues. Despite massive losses, management continues to issue shares to ...

Deal adds fusion power to Trump family's diverse ventures Trump Media to be holding company housing both firms' divisions To start building world's first utility-scale fusion power plant in 2026 ...

Regardless of what you think about Elon Musk — good or bad, fascinated or indifferent — one thing can’t be denied: Elon Musk is a business genius who has started up or grown a huge empire of ...

Like the old saying goes, when the going gets tough, the tough get going. But even the toughest people still need encouragement every now and again. If you’ve encountered setbacks in pursuit of your ...